Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - OTHER LONG-TERM ASSETS
Other Long-term Assets REGN - Regeneron Pharmaceuticals, Inc.
10 B
LAST VALUE
103.82%
2 YEAR CAGR
79.95%
5 YEAR CAGR
63.28%
10 YEAR CAGR